ANDROID 10 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Android 10, and when can generic versions of Android 10 launch?
Android 10 is a drug marketed by Valeant Pharms North and is included in one NDA.
The generic ingredient in ANDROID 10 is methyltestosterone. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methyltestosterone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Android 10
A generic version of ANDROID 10 was approved as methyltestosterone by IMPAX LABS on December 31st, 1969.
Summary for ANDROID 10
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 10 |
Patent Applications: | 4,412 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ANDROID 10 at DailyMed |
Recent Clinical Trials for ANDROID 10
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
St. Olavs Hospital | Phase 4 |
Oslo University Hospital | Phase 4 |
Haukeland University Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ANDROID 10
US Patents and Regulatory Information for ANDROID 10
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharms North | ANDROID 10 | methyltestosterone | TABLET;ORAL | 086450-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |